HDFC Bank adopted a new logo in 1997. Two years later ... The 52-week low price of HDFC Bank Ltd (HDFCBANK) is Rs 1426.8 Aurobindo, Sun Pharma, other pharma stocks in focus after 90-day Trump ...

Aurobindo's manufacturing operations have once again landed the Indian drugmaker in hot water with the U.S. FDA. | ...

Generic Xarelto is a blood thinner medicine that lowers blood clotting. Aurobindo has obtained the Food and Drug ...

Generic drugmaker Aurobindo Pharma has received final approval from the U.S. Food and Drug Administration (U.S. FDA) to manufacture and market Rivaroxaban Tablets USP, 2.5 mg. The approved ...

Aurobindo Pharma has received final approval from the US Food and Drug Administration (USFDA) to manufacture and market Rivaroxaban Tablets USP, 2.5mg, the generic equivalent of Janssen ...

An inhalers and derma products manufacturing plant of Aurobindo Pharma subsidiary Aurolife Pharma LLC in the U.S. has been issued 11 observations by the United States Food and Drug Administration.

Pharma stocks such as Sun Pharma, Aurobindo Pharma, Dr Reddy's Lab, Cipla, Gland Pharma, Zydus Lifesciences and Lupin would be in action on Friday after the US President Donald Trump halted ...

Aurobindo Pharma announced that its subsidiary CuraTeQ Biologics has received successful trial results for its new bone treatment medicine. The drug, called BP16, is a biosimilar of an existing ...

Gland Pharma topped the losses with a drop of almost 6 per cent, followed by Aurobindo Pharma, which fell by almost 5 per cent. Biocon's shares fell more than 4 per cent, and Sun Pharma, Lupin, Laurus ...

Aurobindo Pharma and Gland Pharma have fallen 6-10 per cent each in the past one week and 20-23 per cent in 2025 so far. Glenmark Pharma is down 10 per cent for the week month period and 14.45 per ...

Aurobindo Pharma Ltd ( ($IN:AUROPHARMA) ) has issued an announcement. Aurobindo Pharma Limited has received final approval from the USFDA to ...

Sun Pharma and Aurobindo Pharma, are better insulated from tariffs even though the cost of manufacturing generics in the US is significantly higher, they said. “In the medium term, it would be ...